PLoS ONE (Jan 2020)

PCR for the detection of pathogens in neonatal early onset sepsis.

  • Clarissa Oeser,
  • Marcus Pond,
  • Philip Butcher,
  • Alison Bedford Russell,
  • Philipp Henneke,
  • Ken Laing,
  • Timothy Planche,
  • Paul T Heath,
  • Kathryn Harris

DOI
https://doi.org/10.1371/journal.pone.0226817
Journal volume & issue
Vol. 15, no. 1
p. e0226817

Abstract

Read online

BACKGROUND:A large proportion of neonates are treated for presumed bacterial sepsis with broad spectrum antibiotics even though their blood cultures subsequently show no growth. This study aimed to investigate PCR-based methods to identify pathogens not detected by conventional culture. METHODS:Whole blood samples of 208 neonates with suspected early onset sepsis were tested using a panel of multiplexed bacterial PCRs targeting Streptococcus pneumoniae, Streptococcus agalactiae (GBS), Staphylococcus aureus, Streptococcus pyogenes (GAS), Enterobacteriaceae, Enterococcus faecalis, Enterococcus faecium, Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium, a 16S rRNA gene broad-range PCR and a multiplexed PCR for Candida spp. RESULTS:Two-hundred and eight samples were processed. In five of those samples, organisms were detected by conventional culture; all of those were also identified by PCR. PCR detected bacteria in 91 (45%) of the 203 samples that did not show bacterial growth in culture. S. aureus, Enterobacteriaceae and S. pneumoniae were the most frequently detected pathogens. A higher bacterial load detected by PCR was correlated positively with the number of clinical signs at presentation. CONCLUSION:Real-time PCR has the potential to be a valuable additional tool for the diagnosis of neonatal sepsis.